Form 4: Labcorp Executive Glenn Eisenberg Reports Stock Transactions

Glenn Eisenberg, an Executive Vice President at Labcorp Holdings Inc., reported the vesting of restricted stock units and subsequent tax withholding.

Summary

• On February 6, 2025, Glenn Eisenberg vested 966 shares of common stock from restricted stock units and 255 shares were withheld to cover tax obligations at a price of $247.74.
• Following these transactions, Eisenberg directly owns 32,000 shares of common stock.
• On February 7, 2025, Glenn Eisenberg vested 885 shares of common stock from restricted stock units and 234 shares were withheld to cover tax obligations at a price of $246.27.
• Following these transactions, Eisenberg directly owns 32,651 shares of common stock.
• Eisenberg also holds 4,511 and 3,626 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, so the sentiment is neutral.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is standard practice for publicly traded companies to ensure transparency and compliance with securities regulations.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies like Labcorp.
• Similar filings are regularly made by executives at comparable companies such as Quest Diagnostics (DGX) and Mayo Clinic Laboratories.
• The vesting and subsequent tax withholding of restricted stock units are standard compensation practices.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation and tax obligations.

Key Dates

Keywords

Form 4, Insider Trading, Stock Options, Restricted Stock Units, LABCORP HOLDINGS INC., LH, Glenn A. Eisenberg, Executive Vice President